Mukka Proteins Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹508.9 Cr (+108% YoY), EBITDA ₹50.1 Cr (9.9% margin), PAT ₹17.7 Cr (3.5%). Targets ₹3,000+ Cr revenue by FY30.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Q2 FY27 consolidated revenue ₹508.9 Cr (+108% YoY), EBITDA ₹50.1 Cr (9.9% margin), PAT ₹17.7 Cr (3.5%). Targets ₹3,000+ Cr revenue by FY30.
Mukka Proteins reported Q2 FY27 revenue up 108% YoY to Rs.5,088.70 Mn. The Oman facility began commercial production, adding 37,200 MTPA of capacity.
Mukka Proteins' board approved revised terms to acquire 85,200 equity shares, a 46% stake, in Swachha Eco Solutions for up to Rs 2.13 Crore. The unlisted waste-management company is not a related party.
Mukka Proteins filed its quarterly statement of deviation for funds raised through a preferential warrant issue, reporting no deviation. Utilisation of Rs. 11.75 Crore against the working capital object is shown for the quarter ended September 2026.
Mukka Proteins Ltd reported revenue from operations of ₹508.9 Cr (+108.1% YoY) and net profit of ₹17.7 Cr (+156.5% YoY) for Q2 FY27.